Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Peptides. 2020 Jul 13;131:170369. doi: 10.1016/j.peptides.2020.170369

Figure 16. Glycopeptides Related to the μ-Selective Opioid Agonist DAMGO.

Figure 16.

DAMGO-derived glycopeptides were evaluated for their activity in vivo. Variation in the amphipathic character of the glycopeptide shifted its biological activity in a predictable manner. (Polt 2007) [90].